Senti Biosciences (SNTI) Stock Analysis: AI Score & Alternative Data
SNTI alt-data: web traffic climbing, headcount lagging
Is Senti Biosciences a buy right now? The alternative data says hold. This SNTI stock analysis is built on the 25+ alternative data signals AltIndex tracks on Senti Biosciences every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 46/100: a Hold. The stock trades at $0.42 with a $14M market cap.
The bullish side of the 90-day ledger: web traffic up 15.5% to 6K monthly visits. The drag: headcount (according to LinkedIn) down 7.1% to 65 employees. That tension is what keeps the score mid-range.
SNTI’s broader alt-data profile also covers job postings (1 open roles), X followers (2K), and sentiment (100/100). Every signal links to its own page with full history, the SNTI technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on SNTI is just below.
Senti Biosciences AI Stock Analysis
Senti Biosciences is a biotechnology company that focuses on creating synthetic biology solutions for complex diseases. The company aims to leverage its proprietary gene circuit technology to engineer cells for therapeutic use in areas such as oncology, immunology, and other fields requiring targeted, precise biological activity.
Analysis generated July 31, 2026.
Recent Senti Biosciences Stock Alerts
|
Senti Biosciences | August 17 Price is down by -8.6% in the last 24h. |
|
Senti Biosciences | August 14 Price is up by 6.8% in the last 24h. |
|
Senti Biosciences | August 13 Price is up by 6.6% in the last 24h. |
|
Senti Biosciences | August 12 Price is up by 6.4% in the last 24h. |
Senti Biosciences Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 6K | 15.5% | |
| Job Posts | 1 | 0% | |
| LinkedIn Employees | 65 | 7.1% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 2 | 80.0% | |
| News Mentions | 0 | 100.0% | |
| Stocktwits Subscribers | 3K | 2.3% | |
| X Followers | 2K | 1.0% |
About Senti Biosciences (SNTI)
Senti Biosciences Inc (SNTI) is an innovative biotechnology company at the forefront of synthetic biology, dedicated to pioneering next-generation cell and gene therapies. Utilizing its proprietary GeneCircuit platform, the company is developing programmable therapies aimed at treating a spectrum of diseases, including cancer and genetic disorders, thereby enhancing the precision of personalized medicine. With a robust development pipeline and strong strategic partnerships, Senti is strategically positioned to drive advancements in engineered cell therapies, offering transformative solutions to address critical unmet medical needs in the biopharmaceutical sector.
| Price | $0.42 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $14M |
| Year Range | $0 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Senti Biosciences News
View more →
Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial™ Technology PlatformJuly 15 - GlobeNewswire |
|
Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal PhaseMay 14 - GlobeNewswire |
|
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical ProgramMay 14 - GlobeNewswire |
|
Ophthalmics Collaboration and Licensing Agreements Benchmark Report 2026: Structured Analysis of 374 Deals - Upfronts, Milestones, and Royalty StructuresMay 19 - GlobeNewswire |
Senti Biosciences Earnings & Financial Performance
View all earnings →Senti Biosciences Insider Trading Activity
View all →| Rajangam Kanya filed to sell 8,621 shares at $0.0. Feb 6 '25 |
| Lu Timothy K filed to sell 82,082 shares at $0.0. Feb 6 '25 |
| Rajangam Kanya filed to sell 8,803 shares at $0.0. Feb 4 '25 |
| Lu Timothy K filed to sell 82,627 shares at $0.0. Feb 4 '25 |
| BAYER AKTIENGESELLSCHAFT filed to sell 2,222 shares at $0.0. Dec 9 '24 |
Senti Biosciences Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Senti Biosciences
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Dare BioscienceDARE |
$0.81 12.9% | $14M | 55 |
 |
Bionano GenomicsBNGO |
$1.21 2.1% | $14M | 34 |
 |
AEON BiopharmaAEON |
$0.26 6.2% | $13M | 50 |
 |
Zivo BioscienceZIVO |
$4.05 5.6% | $15M | 44 |
 |
Akari TherapeuticsAKTX |
$7.81 3.6% | $13M | 44 |
Explore Senti Biosciences Data
Frequently Asked Questions: Senti Biosciences (SNTI)
Senti Biosciences has an AltIndex AI Score of 46/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
46/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Senti Biosciences (SNTI) stock is $0.42 with a market cap of $14M.
As of today, Senti Biosciences’s PE (Price to Earnings) ratio is —.
View the latest Senti Biosciences insider transactions to see recent buying and selling activity by company executives and directors.
Check the Senti Biosciences congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The SNTI stock price chart above shows Senti Biosciences’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Senti Biosciences technical analysis for RSI, moving averages, and more.
See the stocks similar to Senti Biosciences section on this page for companies in the same industry ranked by market cap and AI Score.
